jrnl2772

Publication Venue For

  • Poststroke Montreal Cognitive Assessment and Recurrent Stroke in Patients With Symptomatic Intracranial Atherosclerosis.  29. 2020
  • Migraine History: A Predictor of Negative Diffusion-Weighted Imaging in IV-tPA-Treated Stroke Mimics.  28. 2019
  • Cognition and Quality of Life in Symptomatic Carotid Occlusion.  28:2250-2254. 2019
  • Racial Differences in the Association between Parity and Incident Stroke: Results from the REasons for Geographic and Racial Differences in Stroke Study.  26:749-755. 2017
  • Trends in Transcranial Doppler Monitoring in Aneurysmal Subarachnoid Hemorrhage: A 10-Year Analysis of the Nationwide Inpatient Sample.  26:851-857. 2017
  • Diabetes Mellitus with Chronic Complications in Relation to Carotid Endarterectomy and Carotid Artery Stenting Outcomes.  26:217-224. 2017
  • Stroke Symptoms as a Predictor of Future Hospitalization.  25:702-709. 2016
  • A simple prediction score for developing a hospital-acquired infection after acute ischemic stroke.  24:680-686. 2015
  • Family history of stroke and cardiovascular health in a national cohort.  24:447-454. 2015
  • The impact of absent A1 segment on ischemic stroke characteristics and outcomes.  24:171-175. 2015
  • Self-reported sleep duration in relation to incident stroke symptoms: Nuances by body mass and race from the REGARDS study.  23. 2014
  • Investigating the utility of previously developed prediction scores in acute ischemic stroke patients in the stroke belt.  23:2001-2006. 2014
  • Over-the-counter and prescription sleep medication and incident stroke: The REasons for geographic and racial differences in stroke study.  23:2110-2116. 2014
  • Persistent leukocytosis - Is this a persistent problem for patients with acute ischemic stroke?.  23:1939-1943. 2014
  • Predictors of systemic inflammatory response syndrome in ischemic stroke undergoing systemic thrombolysis with intravenous tissue plasminogen activator.  23. 2014
  • Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke.  23. 2014
  • Safety of intravenous tissue plasminogen activator administration with computed tomography evidence of prior infarction.  23:1657-1661. 2014
  • Safety of protocol violations in acute stroke tPA administration.  23:855-860. 2014
  • A proposal for the classification of etiologies of neurologic deterioration after acute ischemic stroke.  22. 2013
  • Acute decrease in serum magnesium level after ischemic stroke may not predict decrease in neurologic function.  22. 2013
  • Infections present on admission compared with hospital-acquired infections in acute ischemic stroke patients.  22. 2013
  • Identification of modifiable and nonmodifiable risk factors for neurologic deterioration after acute ischemic stroke.  22. 2013
  • Short-term bleeding events observed with clopidogrel loading in acute ischemic stroke patients.  22:1184-1189. 2013
  • Clinical features and racial/ethnic differences among the 3020 participants in the secondary prevention of small subcortical strokes (SPS3) trial.  22:764-774. 2013
  • Identifying a high stroke risk subgroup in individuals with heart failure.  22:620-626. 2013
  • Primary prophylactic aspirin use and incident stroke: Reasons for geographic and racial differences in stroke study.  22:500-507. 2013
  • Measured neurological improvements correlate with self-perceived improvements after stroke.  21:659-661. 2012
  • Comparing the use of diagnostic imaging and receipt of carotid endarterectomy in elderly black and white stroke patients.  21:600-606. 2012
  • What stroke symptoms tell us: Association of risk factors and individual stroke symptoms in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  21:411-416. 2012
  • Poststroke aphasia recovery assessed with functional magnetic resonance imaging and a picture identification task.  20:336-345. 2011
  • Awareness, Treatment, and Control of Vascular Risk Factors among Stroke Survivors.  19:311-320. 2010
  • Acute Massive Cerebral Infarctions Treated with Hemodialysis.  18:316-318. 2009
  • Predictors of Clinical Outcome and Mortality in Vertebrobasilar Dolichoectasia Diagnosed by Magnetic Resonance Angiography.  17:388-393. 2008
  • Neural Networks for Ischemic Stroke.  15:223-227. 2006
  • Superiority of fixed-dose warfarin for chronic anticoagulation.  13:118-121. 2004
  • Silent cerebral infarctions in transient ischemic attack populations: Implications of advancing technology.  4:S47-S50. 1994
  • A pilot study of the end point verification system in the asymptomatic carotid atherosclerosis study.  2:92-99. 1992
  • A multicenter validation study of Doppler ultrasound versus angiography.  1:166-173. 1991